Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Protia Highlights CE-IVDR-Certified Allergy and Autoimmune Diagnostic Tests

By LabMedica International staff writers
Posted on 19 Nov 2026

Protia (South Korea) is showcasing its in vitro diagnostic (IVD) solutions at MEDICA 2026, held November 16–19 in Düsseldorf, Germany. More...

The company is highlighting its allergy and autoimmune disease testing portfolio, including the Protia Allergy-Q 192D and Allergy-Q 64D panels and Protia ANA Profile 18, which recently received European certification under the In Vitro Diagnostic Regulation (IVDR). The exhibit also features veterinary allergy testing and antimicrobial susceptibility testing solutions, reflecting Protia’s efforts to expand its presence in international diagnostic markets.

Among the featured products are the Protia Allergy-Q 192D and Allergy-Q 64D multiplex allergy diagnostic panels. The Allergy-Q 192D enables simultaneous testing for 176 allergens, while the Allergy-Q 64D incorporates component-resolved diagnostics (CRD) technology to support allergy testing, including the evaluation of reactions to antibiotics. Both products are designed to assess allergic sensitization through multiplex testing methods.

Protia is also presenting its ANA Profile 18 panel, which simultaneously detects autoantibodies against 18 proteins associated with systemic autoimmune diseases. The assay supports the evaluation of conditions such as systemic lupus erythematosus, Sjögren's syndrome, systemic sclerosis, and inflammatory myopathies. The three diagnostic products received CE-IVDR certification on November 6, 2026, following an assessment of the company's quality management system and technical documentation by European notified body TÜV SÜD Product Service GmbH.

In addition to its human immunodiagnostic products, Protia is exhibiting veterinary allergy testing solutions and antimicrobial susceptibility testing technologies. These offerings extend the company's diagnostic portfolio to animal health and testing applications that support antimicrobial treatment selection.

Protia currently exports its products to approximately 90 countries through a network of around 100 overseas distributors. Through its participation at MEDICA 2026, the company is seeking to strengthen partnerships with hospitals, laboratories, and distributors across Europe, the Middle East, Southeast Asia, Latin America, and Africa, supported by its recent European regulatory certifications.

Related Links
Protia


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.